Esmo Open

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie

Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature

Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations

Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer

Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins

Prospective analysis of 895 patients on a UK Genomics Review Board

The role of hormone therapy and chemotherapy in oligometastatic prostate cancer

PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer